Various studies indicate that the mTOR and STAT3 pathways are significant for psoriasis development; however, in mouse models, mTORC2, not STAT3, deletion results in a mitigated psoriasis profile and changes in the γδ17 T cells profile (142, 143). This evidence concerns the gene STAT3 and psoriasis.